This is a preview of subscription content, log in via an institution to check access.
Notes
The study was sponsored by Novo Nordisk.
Reference
Visaria J, et al. Healthcare Costs of Diabetes and Microvascular and Macrovascular Disease in Individuals with Incident Type 2 Diabetes Mellitus: A Ten-Year Longitudinal Study. ClinicoEconomics and Outcomes Research : 12 Jul 2020. Available from: URL: https://doi.org/10.2147/CEOR.S247498
Rights and permissions
About this article
Cite this article
Vascular disease drives long-term costs in newly diagnosed T2DM. PharmacoEcon Outcomes News 860, 34 (2020). https://doi.org/10.1007/s40274-020-7080-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7080-2